NEUMEIER POMA INVESTMENT COUNSEL LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 246 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEUMEIER POMA INVESTMENT COUNSEL LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$15,133,000
-52.2%
550,676
-42.5%
1.26%
-51.7%
Q2 2019$31,680,000
-4.6%
957,401
+1.1%
2.62%
-6.0%
Q1 2019$33,191,000
+102.1%
947,231
+91.6%
2.79%
+78.8%
Q4 2018$16,422,000
-30.8%
494,331
+4.9%
1.56%
-20.7%
Q3 2018$23,728,000
-7.0%
471,260
+10.6%
1.96%
-17.3%
Q2 2018$25,511,000
+6.4%
426,250
-18.6%
2.37%
-3.8%
Q1 2018$23,969,000
+15.1%
523,350
+0.2%
2.47%
+18.4%
Q4 2017$20,821,000
-27.8%
522,495
-27.6%
2.08%
-30.9%
Q3 2017$28,857,000
-24.8%
721,420
-19.0%
3.02%
-32.6%
Q2 2017$38,391,000
+40.0%
890,740
+1.6%
4.48%
+36.6%
Q1 2017$27,429,000
+39.5%
876,310
+12.5%
3.28%
+21.1%
Q4 2016$19,662,000
-22.3%
778,700
-23.9%
2.71%
-28.7%
Q3 2016$25,297,000
+2.3%
1,022,940
-15.7%
3.79%
-3.0%
Q2 2016$24,720,000
+34.6%
1,213,555
+0.8%
3.91%
+34.3%
Q1 2016$18,360,000
+51.6%
1,203,930
+33.6%
2.91%
+39.0%
Q4 2015$12,114,000901,3302.09%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders